Definium Therapeutics Inc <DFTX.O>: Canaccord Genuity raises target price to $78 from $64
DFTX•Related News
Qualcomm executive Ann Chaplin reports disposal of $665,185.85 in common shares
QCOM•
KinderCare Learning Companies files initial beneficial ownership statement for director Preston Grasty
KLC•
Averin Capital names Graeme Bell compensation committee chair
ACAA•
Cosan board approves contribution of 20.33% Rumo stake to Maglev Fund
CSAN•
LGI Homes announces opening of new community in Weatherford, Texas
LGIH•